Navigation Links
Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings
Date:7/18/2008

(CHICAGO) Neurological experts from across the U.S. and other countries including a nationally renowned researcher from Rush University Medical Center will discuss the latest findings in basic and clinical research for Fragile X at the 11th International Fragile X Conference, to be held July 23-27 in St. Louis. Families with children who are diagnosed with Fragile X also will be attending the conference.

Fragile X, an X-chromosome-linked condition, is the most common inherited cause of mental retardation and the most common known cause of autism or autistic-like behaviors.

Rush's Dr. Elizabeth Berry-Kravis, will be leading a number of discussions at the conference including a plenary session on promising new treatments and clinical sessions on stem cell research, seizures and psychopharmacology. In addition, she will be presenting research on the use of lithium to target the underlying defect in Fragile X Syndrome.

Dr. Berry-Kravis runs the only Fragile X clinic in Chicago and one of the few in the Midwest. Her research program also includes studies of fragile X-associated tremor/ataxia syndrome (FXTAS), a degenerative neurological condition which occurs in fragile X mutation carriers, and she will be presenting research on development of new methods for evaluating risk for FXTAS using a state-of-the-art imaging technique called diffusion tensor imaging.

Schedule of scientific and family friendly sessions led by Dr. Berry-Kravis include:

Plenary sessions:

  • New Treatments on the Near Horizon, Thursday, July 24, 9:45 a.m.
  • Seizure Disorders, Saturday, July 26, 2:45 p.m
  • Five Current Topics of Interest in Psychopharmacology of FXS, Saturday, July 26, 11 a.m.

Research abstract presentations:

  • FXTAS (Fragile X-Associated Tremor/Ataxia Syndrome)
    • Diffusion Tensor Imaging in Male FMR1 Premutation Carriers With and Without FXTAS, Wednesday, July 23, 1:30 p.m.
  • Fragile X Syndrome (FXS)
    • Vocabulary Comprehension in FXS, Wednesday, July 23, 4 p.m.
    • ERK Activation Kinetics as a Biomarker for Metabolic Status in FXS, Saturday, July 26, 9:45 a.m.
  • Medications
    • Open Label Treatment Trial of Lithium to Target the Underlying Defect in FXS

    • Fragile X Conference

    • Atypical Autonomic Regulation in FXS: Contrasts with Normal and Effects of Lithium, Saturday, July 26 1:30 p.m.

Scientific-clinical panel sessions:

  • A Conversation with the Experts: Drug Trials and Adults with -Developmental DisabilitiesEthical Issues and Informed Consent, Thursday, July 24, 11 a.m.
  • Stem Cell Research and Its Implications for Fragile X Research and Treatment, Thursday, July 24, 1:30 p.m.

Family-friendly panel sessions:

  • Psychopharmacology Q & A, Sunday, July 29, 9 a.m.
  • Questions, Answers and Difficult Cases: Treatment Issues, Sunday, July 27, 10:30 a.m.


'/>"/>

Contact: Deb Song
deb_song@rush.edu
312-942-0588
Rush University Medical Center
Source:Eurekalert

Related biology news :

1. As rates rise, researchers find better way to identify melanoma
2. Researchers discover a gene that regulates and blocks ovulation
3. Researchers discover link between organ transplantation and increased cancer risk
4. Dartmouth researchers discover gene signatures for scleroderma
5. URI researcher: China cant fully fix air quality problem for Olympics
6. Louisiana Tech researchers feature drug reformulation in prestigious journal
7. UCLA researchers locate and image prostate cancer as it spreads to lymph nodes
8. UCSB researcher leads worldwide study on marine fossil diversity
9. Researchers catch ion channels in their opening act
10. UGA researchers discover mechanism that explains how cancer enzyme winds up on ends of chromosomes
11. Researchers hack final part of the immune system code
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... , Nov. 29, 2016   Neurotechnology ... and object recognition technologies, today released FingerCell ... fingerprint recognition solutions that run on low-power, ... template using less than 128KB of memory, ... devices that have limited on-board resources, such ...
(Date:11/24/2016)... 23, 2016 Cercacor today introduced Ember TM ... trainers non-invasively measure hemoglobin, Oxygen Content, Oxygen ... Respiration Rate in approximately 30 seconds. Smaller than a ... immediate access to key data about their bodies to ... regimen. Hemoglobin carries oxygen to muscles. ...
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016   Biocept, Inc ... commercial provider of clinically actionable liquid biopsy tests ... that clinical data featuring its Target Selector™ Circulating ... biopsy for the detection of actionable biomarkers in ... research sponsored by Sara Cannon Research Institute (SCRI), ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... journal has concluded that “in the setting of previously treated, advanced pancreatic cancer, ... in defining the optimal patient population and timing of blood sampling may improve ...
(Date:12/7/2016)... 7, 2016 Neogen Corporation (NASDAQ: ... Dan Kephart as its chief science officer — ... his responsibilities at Neogen effective Jan. 1. ... the agribusiness unit of Thermo Fisher Scientific, as well ... Technologies. His extensive industry experience also includes the management ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" ... that will be presented at the Company,s Annual and Special ... of Shareholders will take place on Thursday, December 15, 2016 ... Glenn Hall (Room EC1040), 4825 Mount Royal Gate SW, ... (MST). A notice of meeting and management information circular, containing ...
Breaking Biology Technology: